- TheStreet.com•10 days ago
AstraZeneca shares, meanwhile, were less-than-moved by the news.
- TheStreet.com•2 months ago
The negative investor sentiment for health care stocks in 2016 presented a particularly challenging environment to accomplish anything well. Each of these CEOs met the challenge and succeeded.
- Motley Fool•3 months ago
I should have bought shares of this biotech winner when I had the chance.
MDVN : Summary for Medivation, Inc. - Yahoo Finance